1型神经纤维瘤病:儿童视神经胶质瘤新型诊断评分系统的描述
本研究回顾性分析2003至2016年儿童眶部MRI,将视神经分为NF1伴胶质瘤(71条)、NF1不伴胶质瘤(151条)和健康对照(66条)三组,测量视神经直径并由两名放射科医生评估迂曲度及蛛网膜下腔扩张,提出联合直径与迂曲度的复合评分。结果显示NF1伴胶质瘤组视神经平均直径在所有测量位置均显著大于NF1不伴胶质瘤组和对照组,迂曲度参数均与视神经胶质瘤显著相关,由此衍生的评分系统在区分NF1患者有无视神经胶质瘤方面高度可靠。
要点
- NF1伴视神经胶质瘤患儿视神经平均直径在所有测量位置均显著大于NF1不伴胶质瘤者及健康对照。
- 视神经最大直径超过对照神经最大直径均值2个标准差以上视为异常增大。
- 视神经迂曲度参数均与NF1患者是否存在视神经胶质瘤显著相关。
核心结论
- NF1患者视神经胶质瘤的影像学诊断具有挑战性,所描述的评分系统为这些患者的视神经胶质瘤提供了简单的影像学标准框架。
研究设计与样本
- 回顾性研究,分析2003至2016年儿童眶部MRI,纳入NF1伴胶质瘤71条神经、NF1不伴胶质瘤151条神经、健康对照66条神经;由两名放射科医生评估迂曲度并量化蛛网膜下腔扩张。
关键影像表现/征象
- NF1伴胶质瘤组视神经平均直径在所有测量位置均显著大于NF1不伴胶质瘤组和对照组。
- 视神经最大直径超过对照神经最大直径均值2个标准差以上视为异常增大。
- 视神经迂曲度参数均与NF1患者是否存在视神经胶质瘤显著相关。
诊断标准与关键数值
- 视神经最大直径大于对照神经最大直径均值加2个标准差视为异常增大。
- 联合视神经直径与迂曲度的复合评分系统在区分NF1患者有无视神经胶质瘤方面高度可靠。
临床应用与阅片要点
- 在NF1患儿眶部MRI阅片时,应测量视神经直径并评估迂曲度,注意直径增大和迂曲均可见于无胶质瘤的NF1患儿。
- 所提出的复合评分系统可为NF1患儿视神经胶质瘤的影像学诊断提供简单标准框架。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Neurofibromatosis type 1 (NF1) is a multisystemic genetic disease in which patients develop benign tumors including optic nerve gliomas (ONG). Optic nerve thickening and tortuosity are radiologic markers of tumors but can also be present in children with NF1 who do not have gliomas, thus complicating screening and diagnosis. We undertook this study to retrospectively determine quantitative and qualitative diagnostic criteria using MRI of the orbits for ONG in children with NF1.
MATERIALS AND METHODS: MR images of the orbits obtained from 2003 to 2016 for children with and without NF1 were reviewed. Optic nerves were divided into three groups: NF1 with glioma (n = 71 nerves), NF1 without glioma (n = 151 nerves), and healthy control subjects (n = 66 nerves). The diameter of each nerve was measured at multiple locations. Two radiologists assessed tortuosity using validated criteria, and subarachnoid dilatation was quantified. Last, a composite score using both optic nerve diameter and tortuosity was proposed.
RESULTS: The mean diameter of the optic nerve was significantly larger in patients with NF1 with glioma compared with those with NF1 without glioma and with control subjects at all locations. Maximal nerve diameter greater than 2 SD above the mean maximal diameter for control nerves was considered abnormally enlarged. The tortuosity parameters were all significantly associated with ONG compared with absence of ONG in NF1. A scoring system derived from these data were highly reliable in differentiating ONG from absence of ONG in NF1.
CONCLUSION: The radiologic diagnosis of ONG in patients with NF1 is challenging. The scoring systems we describe provide a framework for simple radiologic criteria for ONG in these patients.
引用
- Eid H, Crevier-Sorbo G, Aldraihem A, et al. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma. AJR Am J Roentgenol. 2019. PMID: 30741560. doi:10.2214/AJR.18.20044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。